SUMMARY A study of splenic function in 28 patients with adult coeliac disease showed no significant correlation between the half life of heat-damaged red cells and either the duration of pre-treatment exposure to gluten or the length of time on a gluten free diet. A significant correlation was found between splenic size and duration of treatment; those patients who had been taking a gluten free diet for the longest time had the smallest spleens. Blood films from 11 of these 28 patients taken before treatment with a gluten free diet were compared with those taken between two and 15 years after the start of treatment. There was no tendency for the hyposplenic changes to regress. In the majority, the changes became more prominent despite strict adherence to the gluten free diet. These findings suggest that splenic atrophy in adult coeliac disease is not reversed by treatment with a gluten free diet and is unlikely to be related to the state of the jejunal mucosa or the duration of initial exposure to gluten.
Splenic atrophy is now widely recognised as an accompaniment of adult coeliac disease. It has been demonstrated using quantitative techniques such as measuring the half life of heat-damaged red cells and splenic size as defined by area of radioactivity on a rectilinear scan.' The recognition of the changes in red cell morphology characteristic of hyposplenism may first alert the physician to the possibility that the patient has adult coeliac disease. 6 The mechanism of splenic atrophy is not known. In inflammatory bowel disease, where splenic atrophy may also occur, improvement in splenic function may follow excision of the diseased bowel.7 However, in coeliac disease the small intestinal lesion is presumed to develop in early childhood after weaning onto gluten containing foods. Even if the hyposplenism were related to the mucosal lesion, the factors determining hyposplenism could have been operating long enough to produce irreversible changes by the time a gluten free diet is started in adult life.
In this study we have examined the serial changes in red cell morphology which occur when patients with adult coeliac disease are treated with a gluten free diet. In patients already taking a gluten free diet we Received for publication 9 January 1981 have examined the relations between quantitative tests of splenic function and the duration of exposure to gluten before treatment as well as the duration of treatment with a gluten free diet.
Methods

PATIENTS
Twenty-eight patients were studied. All had been diagnosed as having adult coeliac disease between two months and 23 years previously on the basis of a typical coeliac lesion on intestinal biopsy. Twenty-six patients were followed up for more than one year after the start of treatment and repeat jejunal biopsies were available in 24. In all but one there was evidence of morphological improvement after treatment with a gluten free diet. In the one patient without morphological improvement serum and red cell folate levels and faecal fat excretion had returned to normal after treatment. The patient subsequently developed a carcinoma of the bronchus and a third jejunal biopsy was not thought to be justifiable. The two patients in whom post-treatment jejunal biopsies were not available had both presented with weight loss, steatorrhoea, and low serum and red cell folate levels. In both, the symptoms resolved and the biochemical and haematological changes returned to normal after treatment with a gluten free diet without folate supplements.
Of the 28 patients, 11 were male and 17 female and their mean age at the time of study was 61 years with a range of 16-81 years. They were all being followed up regularly by the same clinician and a dietician with special training and experience in coeliac disease. Only those who were judged to be eating a strict gluten free diet were included in the study. All patients had normal serum and red cell folate levels in the absence of folate supplements.
Routine blood films were examined from each patient for evidence of hyposplenism. Films were examined by one haematologist without knowledge of the patient ' In 11 of these patients blood films were also available from the time of initial diagnosis, which varied from two to 15 years from the time of the present study. These films were coded and examined blind to provide a paired comparison of the effects of a gluten free diet on red cell morphology. In four patients blood films were available from 14 years before the present study but at a time when the patient had been on treatment with a gluten free diet for between two and nine years. The blood films from these patients were also examined and in these, as well as in the remaining patients, the hyposplenic changes were studied in relation to the length of initial exposure to gluten, the number of years' treatment with a gluten free diet, and the age of the patient.
The half life of damaged red cells was assessed by the method described by Bowring, Glass, and Lewis.8 Autologous red cells were damaged by heating for 20 minutes at 49.5°C. The cells were labelled with "Tcm after pre-tinning with stannous chloride9 and the washed cells were reinjected into the patient. Serial blood sampling allowed the rate of clearance of damaged red cells to be determined and scintillation scanning of the abdomen permitted the spleen to be visualised and its area measured by planimetry. In previous control studies we have found the normal range of heat-damaged red cell half lives to be between eight and 16 minutes and the lower limit of splenic area to be 45 cm2. In the 28 patients the relations between these quantitative tests of splenic function and both the length of initial gluten exposure and the duration of treatment with a gluten free diet were determined.
Statistical analyses were performed using Spearman's rank correlation coefficient and the MannWhitney U Test.
The study was approved by the local ethical committee and each patient gave informed consent. Patients were not selected on account of pre-existing hyposplenism; the tests of hyposplenism were carried out only after the patient had agreed to participate in the study.
Results
When changes in red cell morphology indicative of hyposplenism were examined there was little to suggest any regression after treatment with a gluten free diet. In five of the 11 patients in whom paired films were available before and after starting treatment the hyposplenic changes became more prominent with treatment. In only one patient was treatment associated with a regression of the hyposplenic changes ( Fig. 1) . In all four patients in whom paired films were available after starting treatment the hyposplenic changes progressed with time and Howell-Jolly bodies were found in one patient after 17 years' treatment ( Fig. 1 ).
Taking the patients as a whole, it was found that those who had hyposplenic changes in their peripheral blood film were those who had been on treatment for the longest period of time. The mean duration of treatment in those with hyposplenic changes in the peripheral blood film was 8-7±1 SD 6X2 years and in those without 3-9+1 SD 5 3 years (p<0.01, Table) .
No relation was found between the number of years the patient had been taking gluten before diagnosis and the severity of the hyposplenic changes in the peripheral blood film, the mean length of gluten exposure in those with and without hyposplenic changes being 50.1 ± 1 SD 1641 and 54-1 ± 1 SD 16-1 years respectively.
Analysis of the quantitative tests of splenic function showed eight of the 28 patients to have prolonged red cell half lives and 12 of the 28 small spleens. Seven patients had both small spleens and prolonged red cell half lives and all but one of these had red cell morphological changes of hyposplenism.
An inverse correlation was found between splenic area and the length of time on treatment (Fig. 2) , those patients with the smallest splenic areas having been on treatment for the longest period of time and vice versa. A statistically significant inverse correlation was also found between splenic area and the age of the patient at the time of study (r=-0 46, P<0-02). No correlation was found between splenic area and the duration of gluten exposure before diagnosis (r=0-17). Nor was any significant correlation found between the half life of damaged red cells and the age of the patient (r=0.32), the length of initial gluten exposure (r=0-27), or the number of years treated with a gluten free diet (r=0-095).
Analysis of the relation between the different tests of splenic function showed a significant correlation between splenic area and the half life of heatdamaged red cells (r= -0-48, P<0-02). In addition, those patients with Howell-Jolly bodies in the peripheral blood film had significantly smaller splenic areas than those without (mean values 36-0± 1 SD 12-4 cm2 and 524-A12.3 cm2 respectively, P<0-001). However, there was no difference in red cell half lives between the two groups (mean values 20-1 ± 1 SD 14-4 in those with and 13.9±2-6 minutes in those without Howell-
Jolly bodies).
No abnormality was seen on histological examination of the jejunal biopsy from one patient taken soon after her splenic studies. This patient was selected for a third jejunal biopsy because she had the most Howell-Jolly bodies in the peripheral blood film and the second longest red cell half life of the present series (31 minutes).
Discussion
The with age2 and in our patients there was a significant inverse correlation between the age of the patient and the splenic area. This is also in keeping with previous studies which have shown blood film changes of hyposplenism to be rare in young patients with coeliac disease. ' In dermatitis herpetiformis where splenic atrophy also occurs Pettit et al. 7 found no relation between the associated abnormality ofjejunal morphology and the degree of hyposplenism. Our results suggest a similar dissociation in adult coeliac disease. It may be that the tendency to hyposplenism and the associated lymphoreticular atrophy which occur in adult coeliac disease4 are genetically determined, being related to the presumed genetic determinants of adult coeliac disease but unaffected by treatment of the disease with a gluten free diet.
A practical consideration is that the presence of hyposplenic changes in the peripheral blood film cannot be used as evidence of poor dietary compliance. Howell-Jolly bodies may occur in patients who keep strictly to a gluten free diet and who have normal red cell and serum folate levels as well as normal jejunal morphology. 
